Esmolol is a medicine that is known to be a short-acting cardioselective beta blocker, which aggressively blocks beta-1-adrenergic receptors while having little impact on the beta 2-adrenergic receptors of lung and blood vessel smooth muscles. At high doses, selectivity normally reduces, and the medication will aggressively hinder beta 1 and beta 2-adrenergic receptors.